bucladesine has been researched along with Eosinophilic Leukemia, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akutagawa, H; Mayumi, M; Mikawa, H; Morita, M; Nambu, M; Ohshima, Y; Uenoyama, Y | 1 |
| Shute, J | 1 |
| Kim, KM; Mayumi, M; Mikawa, H; Nambu, M; Tanaka, M; Watanabe, H | 1 |
3 other study(ies) available for bucladesine and Eosinophilic Leukemia, Acute
| Article | Year |
|---|---|
Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1.
Topics: Actins; Blood Proteins; Bucladesine; Calcimycin; Calcium-Transporting ATPases; Cell Differentiation; Culture Media; Dose-Response Relationship, Drug; Eosinophil Granule Proteins; Eosinophils; Humans; Hypersensitivity; Immunoglobulin G; Inflammation; Leukemia, Eosinophilic, Acute; Leukemia, T-Cell; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Phthalazines; Platelet Activating Factor; Polymers; Ribonucleases; Tumor Cells, Cultured | 1993 |
Signal transduction mechanisms in human eosinophils.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blood Proteins; Bucladesine; Calcium Signaling; Cell Differentiation; Cells, Cultured; Chemotaxis, Leukocyte; Cyclic AMP; Cytokines; Enzyme Inhibitors; Eosinophil Granule Proteins; Eosinophil Peroxidase; Eosinophil-Derived Neurotoxin; Eosinophils; Guinea Pigs; Humans; Hypereosinophilic Syndrome; Leukemia, Eosinophilic, Acute; Macaca mulatta; Peroxidases; Phosphorylation; Platelet Activating Factor; Protein Kinase C; Protein Processing, Post-Translational; Proteins; Receptors, Cytokine; Receptors, Fc; Ribonucleases; Signal Transduction; Tumor Cells, Cultured | 1993 |
Regulation of Fc gamma receptor subtype expression on a human eosinophilic leukemia cell line EoL-3: participation of cAMP and protein kinase C in the effects of interferon-gamma and phorbol ester.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antibodies, Monoclonal; Antigens, Differentiation; Bucladesine; Calcium; Cyclic AMP; Dexamethasone; Dose-Response Relationship, Drug; Eosinophils; Flow Cytometry; Humans; Immunoglobulin G; In Vitro Techniques; Interferon-gamma; Isoquinolines; Leukemia, Eosinophilic, Acute; Piperazines; Protein Kinase C; Receptors, Fc; Receptors, IgG; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1991 |